PKN2 and pancreatic neoplasm: Interestingly, in vivo, deletion of stromal PKN2 resulted in more invasive pancreatic tumors, in agreement with studies where myofibroblast phenotype CAFs have been suppressed or ablated (Ozdemir et al., 2014; Rhim et al., 2014).